| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 09/04/2003 | US20030166580 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 09/04/2003 | CA2475653A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 09/03/2003 | EP1340980A1 Derivatives of amphetamine, antibodies against said derivatives, reagent kits, methods of producing said antibodies, and methods of detecting said derivatives |
| 09/03/2003 | EP1340744A2 Hiv protease inhibitors |
| 09/03/2003 | EP1340740A1 Carboxylic acid type lipid |
| 09/03/2003 | EP1339702A1 5-amide substituted diarylamines as mek inhibitors |
| 09/03/2003 | EP1339685A2 Biphenylcarboxamides useful as lipid lowering agents |
| 09/03/2003 | EP1339675A1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds |
| 09/03/2003 | EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 09/03/2003 | EP1339669A2 N-alkylated gaba compounds, processes for their preparation and their use as medicaments |
| 09/03/2003 | CN1440396A Colchinol derivatives as angiogenesis inhibitors |
| 09/03/2003 | CN1440382A Method for separating ammoniac |
| 09/03/2003 | CN1440381A Process for preparation of substituted octanoyl amides |
| 09/03/2003 | CN1120148C Process for iohexol manufacture |
| 09/02/2003 | US6613876 β-polypeptide foldamers of well-defined secondary structure |
| 09/02/2003 | US6613801 Method for the synthesis of compounds of formula I and their uses thereof |
| 09/02/2003 | US6613769 Tryptase inhibitors |
| 09/02/2003 | US6613764 Aspartic protease inhibitors |
| 08/28/2003 | WO2002072534A3 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
| 08/28/2003 | US20030162799 Squaric acid derivatives |
| 08/28/2003 | US20030162724 Such as tris(4-(N-alpha-(2-(1H-indol-3-yl)acetyl)-L-lysyl)aminophenyl)methane hydrochloride for treatment of thrombocytopenia |
| 08/28/2003 | US20030162293 Cell transfection compositions comprising genetic material, an amphipathic compound and an enzyme inhibitor and method of use |
| 08/27/2003 | EP1337505A1 A process for the preparation of n,n'-substituted 5-amino-1,3-benzenedicarboxamides |
| 08/27/2003 | EP1337504A2 Novel polyamine analog-amino acid conjugates useful as anticancer agents |
| 08/27/2003 | CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 08/27/2003 | CN1119328C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists |
| 08/26/2003 | US6610886 Intermediate for preparing midodrine |
| 08/26/2003 | US6610850 Contrast media for angiography |
| 08/26/2003 | US6610650 Modulation of cellular transcription factor activity |
| 08/26/2003 | US6610329 Compositions for the delivery of antigens |
| 08/21/2003 | WO2003068242A1 Phospholipids as caspase inhibitor prodrugs |
| 08/21/2003 | WO2003032893A3 Assignment |
| 08/21/2003 | WO2002032855A3 Mono- and polyamides of perfluoroalkyl-substituted unsaturated acids |
| 08/21/2003 | WO2002020463A3 Fxr modulators |
| 08/21/2003 | WO2002002512A3 Compounds to treat alzheimer's disease |
| 08/21/2003 | US20030158176 Quaternary ammonium compounds |
| 08/20/2003 | EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 08/20/2003 | EP1133466B1 A process for the preparation of n,n'-bis 2, 3-dihydroxypropyl] -5-[(hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamide |
| 08/20/2003 | EP0923542B1 Aryl substituted cyclic amines as selective dopamine d3 ligands |
| 08/20/2003 | CN1437581A Glucagon antagonists/inverse agonists |
| 08/20/2003 | CN1437578A (P-amino-hyaroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 08/20/2003 | CN1437576A Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 08/20/2003 | CN1118476C Antiviral protease inhibitors |
| 08/19/2003 | US6608067 Inhibitors of serine proteases, particularly HCV NS3 protease |
| 08/19/2003 | CA2071674C Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme |
| 08/19/2003 | CA2045972C Optically active n-.alpha.-fluoroacryloylamino acid derivatives and optically active polymers thereof for the resolution of racemates |
| 08/14/2003 | WO2003066613A1 N-phenyl-2-pyrimidine-amine derivatives |
| 08/14/2003 | WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 08/14/2003 | WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto |
| 08/14/2003 | WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 08/14/2003 | WO2003024955A3 Small molecule inhibitors of caspases |
| 08/14/2003 | WO2002092562A3 Enantioselective reactions using two-component chiral phase transfer catalysts in multiphasic systems |
| 08/14/2003 | WO2002011714A3 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 08/14/2003 | US20030153788 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents |
| 08/14/2003 | US20030153611 Antitumor agents promoting the detachment of endothelial cells forming tumor, inhibiting tubulin polymerization |
| 08/14/2003 | US20030153537 Reducing tetracycline resistance in living cells |
| 08/14/2003 | CA2737565A1 N-phenyl-2-pyrimidine-amine derivatives |
| 08/14/2003 | CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 08/12/2003 | US6605632 Affinity for melatonin receptors |
| 08/12/2003 | US6605626 Antithrombotic agents |
| 08/12/2003 | US6605625 Antiarrhythmia agents |
| 08/07/2003 | WO2003064501A1 Conformationally restricted compounds as dendrimer cores |
| 08/07/2003 | WO2003064377A1 4,5-substituted-2-formylaminobenzamides and processes for their production and conversion |
| 08/07/2003 | WO2003064376A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps) |
| 08/07/2003 | WO2003064375A1 New opioid derivative |
| 08/07/2003 | WO2003063852A1 Therapeutic agent for urinary incontinence |
| 08/07/2003 | US20030149303 Simultaneous halogenation and hydroxylation under lactonization, azidation, then amination to form 2(S),4(S),5(S),7(S)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides |
| 08/07/2003 | US20030149107 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 08/07/2003 | US20030149015 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
| 08/07/2003 | US20030149003 Functionalized stilbene derivatives as improved vascular targeting agents |
| 08/06/2003 | CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 08/06/2003 | CN1434794A Adamantane derivatives |
| 08/06/2003 | CN1117069C Process for preparation of inorganic salt of optical phenylglycine derivative |
| 08/05/2003 | US6603043 Reacting alpha -alkyl-alpha-aminonitrile with a base and the aldehyde to form Schiff base |
| 08/05/2003 | CA2044210C Compositions containing nitroaniline dyes having a carbamide substituent group |
| 07/31/2003 | WO2003062191A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/31/2003 | WO2003062189A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/31/2003 | WO2003061698A1 6-fluorobicyclo[3.1.0]hexane derivatives |
| 07/31/2003 | US20030144542 Use of propargyl glycine amino propargyl diol compounds for treatment of renal failure |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/31/2003 | US20030143146 Method for separating ammoniac |
| 07/31/2003 | US20030140431 3-(2,5-Diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 07/31/2003 | CA2473545A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/31/2003 | CA2472367A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/30/2003 | EP1330430A2 Integrin receptor inhibitors |
| 07/30/2003 | EP1330429A2 Alkynyl amides and their therapeutic applications |
| 07/30/2003 | CN1433397A Method for the prepararation of enantiomerically enriched compounds |
| 07/30/2003 | CN1432559A Glutamine extracting process from fermented liquid |
| 07/29/2003 | US6600045 This invention relates to methods for preparing certain cholesteryl ester transfer protein (CETP) inhibitors and intermediates useful in the preparation of said CETP inhibitors. |
| 07/29/2003 | US6599721 Chemical intermediates; hydrolysis using hydrolases |
| 07/24/2003 | WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof |
| 07/24/2003 | WO2003059866A1 Geranyl compounds |
| 07/24/2003 | US20030139418 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 07/24/2003 | CA2706833A1 Geranyl compounds |
| 07/24/2003 | CA2706826A1 Geranyl compounds |
| 07/23/2003 | EP1328508A2 Propionic acid derivatives with ppar-alpha activating properties |
| 07/23/2003 | CN1115145C Improving tolerability of pharmaceutically active beta-amino acids |
| 07/22/2003 | US6596904 5-Amino-N,N*-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalam ide is reacted with chloroacetyl chloride in polar aprotic solvents; reacting with base; hydroxyethylation |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |